Rise-L
Device Spine
General payments
$3,718,588
Research payments
$1,045
Through program year 2022, $3,718,588 in general payments and $1,045 in research payments were reported against Rise-L (Spine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $1,067,372 | 458 |
| 2020 | General | $399,131 | 54 |
| 2019 | General | $2,252,085 | 340 |
| 2019 | Research | $1,045 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
852 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.